Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

AORT

ARTIVION, INC.

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 784199Held by 3 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$441.0M
Net Income FY2025
$10.0M
EPS (Basic, as reported)
$0.22
Net Margin FY2025
2.2%
ROE FY2025
2.2%
Total Equity
$448.0M
Shares Out
49M
Business description

ARTIVION, INC. — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 180 → 441 +10.5% CAGR
Revenue180190263276253299314354389441
Cost of revenue(61)(61)(90)(93)(85)(101)(111)(125)(140)(157)
Gross profit119129173183168198203229249284
Research & development(13)(19)(23)(23)(24)(36)(39)(29)(28)(31)
Selling, general & administrative(92)(101)(141)(143)(141)(170)(157)(209)(181)(226)
Total operating expenses(105)(121)(164)(166)(165)(205)(196)(238)(210)(257)
Operating income22891728663934
Interest expense(3)(5)(16)(15)(17)(17)(18)(25)(34)(27)
Interest & investment income0001000111
Other income (expense), net000(1)(3)(6)(3)(3)(10)10
Pre-tax income184(6)2(17)(15)(15)(22)(8)15
Income tax expense(8)0(4)000(4)(9)(6)(5)
Net income114(3)2(17)(15)(19)(31)(13)10
EPS — basic$0.33$0.11($0.08)$0.05($0.44)($0.38)($0.48)($0.75)($0.32)$0.22
EPS — diluted$0.32$0.11($0.08)$0.05($0.44)($0.38)($0.48)($0.75)($0.32)$0.21
Shares outstanding — basic (M)32333637383940414245
Shares outstanding — diluted (M)33343638383940414247

Showing the latest 10 of 17 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.